Tobacco use is the leading preventable cause of mortality in the world. The limited number of smoking cessation aids currently available are minimally effective, highlighting the need for novel therapeutic interventions. We describe a genome-wide approach to identify potential candidates for such interventions. next-generation sequencing was performed using RnA isolated from the habenulointerpeduncular circuit of male mice withdrawn from chronic nicotine treatment. this circuit plays a central role in the nicotine withdrawal response. Differentially expressed miRNAs and mRNAs were validated using RT-qPCR. Many of the differentially expressed mRNAs are predicted targets of reciprocally expressed miRnAs. We illustrate the utility of the dataset by demonstrating that knockdown in the interpeduncular nucleus of a differentially expressed mRNA, that encoding profilin 2, is sufficient to induce anxiety-related behavior. Importantly, profilin 2 knockdown in the ventral tegmental area did not affect anxiety behavior. Our data reveal wide-spread changes in gene expression within the habenulo-interpeduncular circuit during nicotine withdrawal. this dataset should prove to be a valuable resource leading to the identification of substrates for the design of innovative smoking cessation aids.Tobacco use is a prevalent health problem worldwide, with more than 900 million daily smokers 1 and an estimated 6 million deaths due to tobacco-related illnesses annually 2 . The few pharmacological cessation aids currently available have limited efficacy 3-6 . Without the intervention of new effective treatments, tobacco-related mortality is anticipated to rise to 8 million deaths per year 2 .The addictive component of tobacco is nicotine, an agonist of nicotinic acetylcholine receptors (nAChRs), ligand-gated ion channels endogenously activated by acetylcholine 7 . nAChRs are enriched in the mesolimbic and habenulo-interpeduncular circuitries involved in nicotine reward and withdrawal, respectively 8-10 . Cessation of nicotine induces a withdrawal syndrome consisting of negative somatic, affective and cognitive symptoms. Affective symptoms include depressed mood, irritability, craving and anxiety 11,12 . While the rewarding properties of nicotine dominate initial drug-taking, it is largely avoidance of affective withdrawal symptoms that promotes relapse and habitual use 13,14 .The habenulo-interpeduncular circuitry consists primarily of neurons projecting from the medial habenulae (MHb) to the interpeduncular nucleus (IPN) via the fasciculus retroflexus. In mice experiencing spontaneous nicotine withdrawal, there is increased glutamate release from habenular axon terminals, activating GABAergic neurons in the IPN 15 . Activation of the IPN results in the increased somatic signs and anxiety observed during nicotine withdrawal 15,16 . Optogenetic investigation of this circuit has revealed that silencing the MHb decreases activation of IPN neurons and decreases anxiety during nicotine withdrawal 16 .While much is known about the neurocircu...